Загрузка...
Pazopanib in the management of advanced soft tissue sarcomas
Therapy of soft tissue sarcomas represents an area of significant unmet need in oncology. Angiogenesis has been explored as a potential target both preclinically and clinically, with suggestions of activity. Pazopanib is a multitargeted tyrosine kinase inhibitor with prominent antiangiogenic effects...
Сохранить в:
| Опубликовано в: : | Ther Clin Risk Manag |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907704/ https://ncbi.nlm.nih.gov/pubmed/27354810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S84792 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|